In a report released on February 6, Arun Viswanathan from RBC Capital maintained a Buy rating on Corteva (CTVA – Research Report), with a price target of $64.00. The company’s shares closed yesterday at $54.07.
According to TipRanks, Viswanathan is a 4-star analyst with an average return of 4.7% and a 54.66% success rate. Viswanathan covers the Basic Materials sector, focusing on stocks such as LyondellBasell, Corteva, and Huntsman.
Corteva has an analyst consensus of Moderate Buy, with a price target consensus of $60.22, implying an 11.37% upside from current levels. In a report released on February 2, Deutsche Bank also maintained a Buy rating on the stock with a $62.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
CTVA market cap is currently $36.5B and has a P/E ratio of 50.57.
Based on the recent corporate insider activity of 62 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CTVA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Corteva (CTVA) Company Description:
Corteva, Inc. is an agricultural chemical and seed company. It develops and supplies advanced germplasm and traits that helps in maximizing yield for farms. It also supplies products that enhances enhance crop health and protectagainst weeds, insects and other pests, and diseases.
Read More on CTVA:
